Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04480203

Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
390 (estimated)
Sponsor
Norwegian Institute of Public Health · Other Government
Sex
Female
Age
20 Years – 69 Years
Healthy volunteers
Not accepted

Summary

1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.

Detailed description

After completing the baseline HRQoL assessment, eligible breast cancer patients will be invited to participate in a randomized clinical trial. Those who are willing will be randomly allocated to one of the following arms: a) Digital cognitive based stress management, b) Digital mindfulness based intervention or c) Control group. The intervention is based on a revised version of the Stressproffen app, which was developed by the Oslo University Hospital (Lise Solberg Nes, Elin Børøsund and others). Outcome measures include measures of perceived stress and HRQoL.

Conditions

Interventions

TypeNameDescription
OTHERStressproffen cognitive based stress managementThe participants will download an app (Stressproffen 2A) with cognitive based stress management.
OTHERStressproffen mindfulness based interventionThe participants will download an app (Stressproffen 2B) with mindfulness based intervention.
OTHERControlThe participants will receive no app. (They will be able to download it after the end of the 3 year study).

Timeline

Start date
2021-01-15
Primary completion
2023-08-31
Completion
2035-12-31
First posted
2020-07-21
Last updated
2022-03-02

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04480203. Inclusion in this directory is not an endorsement.